Screening for Wilms tumor in high-risk individuals

Area of Science:

• Pediatric Oncology
• Clinical Genetics
• Molecular Biology

Background:

• Genetic syndromes are associated with Wilms tumor, necessitating surveillance protocols.
• Empiric risk estimates have guided the development of screening protocols for high-risk individuals.
• Clinical evaluation and screening protocols for Wilms tumor have been significantly refined.

Purpose of the Study:

• To improve clinical characterization of Wilms tumor syndromes.
• To prospectively assess Wilms tumor occurrence in high-risk phenotypes through a patient registry.
• To enhance surveillance mechanisms for high-risk individuals using molecular genetic advancements.

Main Methods:

• Clinical evaluation of high-risk individuals.
• Development and refinement of screening protocols.
• Generation of a patient registry for prospective assessment.
• Leveraging molecular genetic technologies to understand causative factors.

Main Results:

• Molecular characterization of specific syndromes (e.g., BWS, DDS, familial Wilms tumor, aniridia) influences clinical management.
• Involvement of clinical genetics enhances patient care and risk assessment.
• Collaboration across disciplines (genetics, molecular biology, oncology, pediatrics) advances understanding.

Conclusions:

• Continued clinical characterization and a patient registry are crucial for Wilms tumor surveillance.
• Molecular genetic insights are improving surveillance and clinical management of high-risk patients.
• A multidisciplinary approach involving clinical genetics is key to precise Wilms tumor risk assessment and understanding tumor genesis.